Pierre fabre pharmaceuticals

All our news. Most recently, she was Head of US Medical Affairs for their Cell Therapy franchise, contributing significantly to bringing to market several drugs to treat hematologic malignancies. Indication: Proliferating infantile hemangioma requiring systemic therapy. Get in touch with Pierre Fabre using your region's corporate website.

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty. Pierre Fabre New ways to care For 60 years, we have been innovating relentlessly to take care of everyone. Our latest. Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology.

Pierre fabre locations

Respect the farmers and harvesterss We respect the farmers and harvesters we work with, and help develop the regions from which we source our ingredients Find out more. Every time we share the fruit of our efforts with those working and living beside us As Business Operations Lead, Arthur Ginies oversees the operational functions of the organization, with a particular focus on leading the launch management for Pierre Fabre's first US allogeneic T-cell immunotherapy candidate.

Having relocated to New York City, he enjoys walking around the lively streets of Manhattan and planning his travels. Prior to joining the executive team, he led the US Market Access launch for a gene therapy product indicated for the treatment of severe hemophilia A. Our ambition is to be a partner of choice for biotechs bringing innovative therapies to market.

Her philosophy and approach are rooted in co-creating patient-centric services, programs, and educational resources alongside patients, caregivers, advocacy organizations, and healthcare providers. Every time we innovate to help each person live better Josh brings a demonstrated ability to develop effective strategies in complex and competitive markets, drawing on his cross-functional experience in market access, marketing, and medical affairs.

Thanks to our conviction and drive, we use sustainable innovation to benefit Nature and People, focusing on 5 pillars. Our Commitments. Thanks to our conviction and drive, we use sustainable innovation to benefit Nature and People, focusing on 4 issues:. Before joining Pierre Fabre Pharmaceuticals, Elizabeth served as Executive Director, Head of Patient Experience at Kite Pharma, where she successfully led the development and execution of an organization-wide patient experience strategy.

Pierre fabre pharmaceuticals stock

As Head of the US Commercial organization, Seung Hyung-Moon spearheads the development and execution of commercial strategies to help unlock the potential of cell therapy and rare disease treatments for patients with high unmet medical need. Most of all, we emphasize creating long-term value for patients and society. Pierre Fabre New ways to care Discover the group.

Disease Area: Hematology. With a rich biopharma background in leading and building innovative private or public biotech companies, Moon possesses a comprehensive understanding of commercial, medical, clinical, and business development functions. Every time the Pierre Fabre Foundation improves access to healthcare for those most in need We help patients live better by designing and developing therapeutic solutions.

Revenue in International FR EN.